Mainz Biomed B.V.

NASDAQ:MYNZ

0.22 (USD) • At close November 7, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

20232022202120202019
Assets:
Current Assets:
Cash & Cash Equivalents 7.07117.1428.7280.1230.204
Short Term Investments 00000
Cash and Short Term Investments 7.07117.1428.7280.1230.204
Net Receivables 0.3550.2590.1120.0440.041
Inventory 0.6140.175-863.1400
Other Current Assets 0.941801.959863.910.020.016
Total Current Assets 8.9818.3789.6090.1860.26
Non-Current Assets:
Property, Plant & Equipment, Net 3.0341.8390.4320.4870.456
Goodwill 00000
Intangible Assets 3.3950000
Goodwill and Intangible Assets 3.3950000
Long Term Investments 00000
Tax Assets 00000
Other Non-Current Assets 00.023-0.432-0.4870
Total Non-Current Assets 6.4291.8630.4320.4870.456
Total Assets 15.40920.24110.0410.6730.716
Liabilities & Equity:
Current Liabilities:
Account Payables 2.3591.3330.8330.2490.2
Short Term Debt 5.2251.3260.2490.2670.207
Tax Payables 000.0030.020.005
Deferred Revenue 0.1390.19900.0020.003
Other Current Liabilities 1.5141.3840.2710.1850.05
Total Current Liabilities 9.2374.2431.3520.7020.46
Non-Current Liabilities:
Long Term Debt 2.1961.9022.3282.7132.207
Deferred Revenue Non-Current 00000
Deferred Tax Liabilities Non-Current 00000
Other Non-Current Liabilities 0.7270000
Total Non-Current Liabilities 2.9231.9022.3282.7132.207
Total Liabilities 12.166.1453.683.4152.666
Equity:
Preferred Stock 00000
Common Stock 0.2360.1650.1410.1060.106
Retained Earnings -69.328-43.032-16.645-4.955-4.368
Accumulated Other Comprehensive Income/Loss 20.83418.1329.7392.1072.312
Other Total Stockholders Equity 51.50838.83213.12600
Total Shareholders Equity 3.24914.0966.361-2.742-1.95
Total Equity 3.24914.0966.361-2.742-1.95
Total Liabilities & Shareholders Equity 15.40920.24110.0410.6730.716